What are the risk factors for venous thromboembolism in postpartum mothers?

Risk Factors for Venous Thromboembolism in Postpartum Mothers

All postpartum women face elevated VTE risk, but specific maternal and obstetric factors dramatically increase this baseline risk and should trigger systematic risk stratification using validated frameworks.

Risk Factor Classification

The American College of Chest Physicians (ACCP) and Royal College of Obstetricians and Gynaecologists (RCOG) provide the most comprehensive risk stratification systems, categorizing factors by their strength of association with VTE 1.

Major Risk Factors (Odds Ratio >6)

These factors independently confer substantial VTE risk and warrant pharmacologic prophylaxis:

• Previous VTE (strongest predictor; OR 62.1 in recent data) 2
• Immobility for ≥1 week antepartum
• Postpartum hemorrhage requiring surgery
• Preeclampsia with fetal growth restriction 1
• High-risk thrombophilias:
  • Antithrombin deficiency
  • Homozygous Factor V Leiden
  • Homozygous prothrombin G20210A mutation
  • Compound heterozygous (Factor V Leiden + prothrombin mutation)
• Blood transfusion
• Postpartum infection 1
• Systemic lupus erythematosus
• Heart disease
• Sickle cell disease

Minor Risk Factors (OR 2-6)

Two or more minor factors, or one minor factor with emergent cesarean delivery, elevate risk above the 3% threshold where prophylaxis benefits outweigh harms 1:

• Obesity (particularly BMI >40 kg/m²) 1
• Multiple pregnancy 2, 3
• Postpartum hemorrhage (without surgery) 4
• Smoking
• Fetal growth restriction
• Preeclampsia/eclampsia (OR 2.89) 4
• Low-risk thrombophilias (Protein C or S deficiency, heterozygous Factor V Leiden or prothrombin mutation)

Obstetric and Delivery-Related Factors

Cesarean delivery is consistently identified as an independent risk factor (OR 2.1) 2, with emergent cesarean conferring higher risk than elective procedures 1. The RCOG classifies cesarean delivery during labor as intermediate risk even without additional factors 1.

Additional obstetric risks include:

• Advanced maternal age (≥35 years; OR increases with age, reaching 5.46/10,000 deliveries in women ≥40) 3
• Multiparity (≥3 prior deliveries) 1, 3
• Preterm delivery <37 weeks (OR 1.6) 2
• Prolonged labor >24 hours 1
• Operative vaginal delivery 1
• Stillbirth 1

High-Risk Medical Conditions

The RCOG identifies specific medical conditions warranting extended prophylaxis 1:

• Cancer (active malignancy)
• Heart failure
• Active systemic lupus erythematosus
• Nephrotic syndrome
• Type 1 diabetes with nephropathy
• Inflammatory bowel disease
• Intravenous drug use

Temporal Risk Distribution

The postpartum period carries the highest VTE risk, with 62.9% of pregnancy-associated VTE occurring postpartum 3. The daily risk is up to 60-fold higher than the non-pregnant state during this period 5. Risk peaks immediately after delivery and remains elevated for 6 weeks, with most events occurring within the first week 4.

Clinical Application Algorithm

Step 1: Identify any major risk factor → If present, initiate combined mechanical and pharmacologic prophylaxis for 6 weeks postpartum 1

Step 2: If no major factors, count minor risk factors:

• ≥2 minor factors → Pharmacologic prophylaxis indicated
• 1 minor factor + emergent cesarean → Pharmacologic prophylaxis indicated
• 1 minor factor alone → Mechanical prophylaxis only
• No risk factors → Early mobilization only 1

Step 3: For cesarean delivery specifically:

• All cesarean deliveries → Sequential compression devices starting preoperatively 1
• Cesarean during labor → Consider intermediate-risk category (RCOG framework) 1
• Elective cesarean with any additional risk factor → Add pharmacologic prophylaxis 1

Critical Caveats

D-dimer interpretation: While elevated D-dimer (>2.24 mg/L) has 88.9% sensitivity for postpartum PE 6, physiologic elevation occurs normally postpartum. Use D-dimer for risk stratification in symptomatic patients, not routine screening 4.

Guideline discrepancies: Applying RCOG criteria would classify 85% of cesarean deliveries for prophylaxis versus only 1% under ACOG criteria 1. The ACCP framework (34.8% requiring prophylaxis) represents a middle ground based on 3% absolute VTE risk threshold 1.

Race and ethnicity: Current risk models may not adequately account for population-specific variations. Japanese data show 1/1000 incidence 2, while Korean data demonstrate 3.2-fold increase over recent years 3, suggesting evolving epidemiology.

Antiphospholipid syndrome: These patients require prophylactic or therapeutic anticoagulation regardless of delivery mode, extending throughout the puerperium 1.

The evidence strongly supports systematic risk assessment using either ACCP or RCOG frameworks, with institutional protocols mandatory for consistent application 1. The number needed to treat ranges from 640-4000 depending on risk stratification 1, while number needed to harm (wound complications) may be as low as 200 1, emphasizing the importance of accurate risk assessment rather than universal prophylaxis.